Phase II trial of lapatinib and topotecan (LapTop) in patients with platinum-refractory/resistant ovarian and primary peritoneal carcinoma

S. John Weroha, Ann L. Oberg, Katie L.Allen Ziegler, Shaker R. Dakhilm, Kendrith M. Rowland, Lynn C. Hartmann, Dennis F. Moore, Gary L. Keeney, Prema P. Peethambaram, Paul Haluska

Research output: Contribution to journalArticle

43 Scopus citations

Fingerprint Dive into the research topics of 'Phase II trial of lapatinib and topotecan (LapTop) in patients with platinum-refractory/resistant ovarian and primary peritoneal carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences